Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

PET/CT

  • Predicting Outcomes of Indeterminate Bone Lesions on <sup>18</sup>F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer
    You have access
    Predicting Outcomes of Indeterminate Bone Lesions on 18F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer
    Tim E. Phelps, Stephanie A. Harmon, Esther Mena, Liza Lindenberg, Joanna H. Shih, Deborah E. Citrin, Peter A. Pinto, Bradford J. Wood, William L. Dahut, James L. Gulley, Ravi A. Madan, Peter L. Choyke and Baris Turkbey
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 395-401; DOI: https://doi.org/10.2967/jnumed.122.264334
  • Fetal Dose from PET and CT in Pregnant Patients
    You have access
    Fetal Dose from PET and CT in Pregnant Patients
    Christiane Sarah Burton, Kirk Frey, Frederic Fahey, Mark S. Kaminski, Richard K.J. Brown, Judith M. Pohlen and Barry L. Shulkin
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 312-319; DOI: https://doi.org/10.2967/jnumed.122.263959
  • Lack of Adherence to Guideline-Based Imaging Before Subsequent Radiation in Patients with Non–Small Cell Lung Cancer: Impact on Patient Outcomes
    You have access
    Lack of Adherence to Guideline-Based Imaging Before Subsequent Radiation in Patients with Non–Small Cell Lung Cancer: Impact on Patient Outcomes
    Emily Sterbis, Rifei Liang, Premal Trivedi, Jennifer Kwak, Erica Cohen Major, Sana D. Karam and Rustain L. Morgan
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 75-81; DOI: https://doi.org/10.2967/jnumed.122.264131
  • First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using <sup>18</sup>F-labeled Active-Site Inhibited Factor VII (<sup>18</sup>F-ASIS): Potential as Companion Diagnostic
    You have access
    First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic
    Mathias Loft, Camilla Christensen, Malene M. Clausen, Esben A. Carlsen, Carsten P. Hansen, Niels Kroman, Seppo W. Langer, Claus Høgdall, Jacob Madsen, Nic Gillings, Carsten H. Nielsen, Thomas L. Klausen, Søren Holm, Annika Loft, Anne K. Berthelsen and Andreas Kjaer
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1871-1879; DOI: https://doi.org/10.2967/jnumed.122.264068
  • <sup>89</sup>Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer
    You have access
    89Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer
    Kang H. Zheng, Jeffrey Kroon, Jasper Schoormans, Oliver Gurney-Champion, Sybren L. Meijer, Suzanne S. Gisbertz, Maarten C.C.M. Hulshof, Danielle J. Vugts, Guus A.M.S. van Dongen, Bram F. Coolen, Hein J. Verberne, Aart J. Nederveen, Erik S.G. Stroes and Hanneke W.M. van Laarhoven
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1880-1886; DOI: https://doi.org/10.2967/jnumed.121.263330
  • <sup>18</sup>F-FDG PET/CT–Based Prognostic Survival Model After Surgery for Head and Neck Cancer
    You have access
    18F-FDG PET/CT–Based Prognostic Survival Model After Surgery for Head and Neck Cancer
    Gwenaelle Creff, Franck Jegoux, Xavier Palard, Adrien Depeursinge, Ronan Abgral, Remi Marianowski, Jean-Christophe Leclere, Thomas Eugene, Olivier Malard, Renaud De Crevoisier, Anne Devillers and Joel Castelli
    Journal of Nuclear Medicine September 1, 2022, 63 (9) 1378-1385; DOI: https://doi.org/10.2967/jnumed.121.262891
  • Brown Adipose Tissue: A Protective Mechanism Against “Preprediabetes”?
    You have access
    Brown Adipose Tissue: A Protective Mechanism Against “Preprediabetes”?
    John P. Crandall, Tyler J. Fraum and Richard L. Wahl
    Journal of Nuclear Medicine September 1, 2022, 63 (9) 1433-1440; DOI: https://doi.org/10.2967/jnumed.121.263357
  • Head-to-Head Comparison of <sup>68</sup>Ga-FAPI-46 and <sup>18</sup>F-FDG PET/CT for Evaluation of Head and Neck Squamous Cell Carcinoma: A Single-Center Exploratory Study
    You have access
    Head-to-Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT for Evaluation of Head and Neck Squamous Cell Carcinoma: A Single-Center Exploratory Study
    Chetsadaporn Promteangtrong, Dheeratama Siripongsatian, Attapon Jantarato, Anchisa Kunawudhi, Peerapon Kiatkittikul, Sukanya Yaset, Natphimol Boonkawin and Chanisa Chotipanich
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1155-1161; DOI: https://doi.org/10.2967/jnumed.121.262831
  • Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with <sup>18</sup>F-FDG PET/CT: A Single-Center Prospective Study
    You have access
    Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with 18F-FDG PET/CT: A Single-Center Prospective Study
    Louise M. Risør, Malene M. Clausen, Zaza Ujmajuridze, Mohammed Farhadi, Kim F. Andersen, Annika Loft, Jeppe Friborg and Andreas Kjaer
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1169-1176; DOI: https://doi.org/10.2967/jnumed.121.262866
  • <sup>68</sup>Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy
    You have access
    68Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy
    Qaid Ahmed Shagera, Carlos Artigas, Ioannis Karfis, Gabriela Critchi, Nieves Martinez Chanza, Spyridon Sideris, Alexandre Peltier, Marianne Paesmans, Thierry Gil and Patrick Flamen
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1191-1198; DOI: https://doi.org/10.2967/jnumed.121.263006

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 32
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire